Shweta Bansal, MD, MBBS, FASN
Professor of Medicine
“A born Nephrologist” or “her passion for nephrology is contagious”, these are the statements I am identified with and truly, that is who I am, a passionate, hard-working, and life-loving nephrologist, who strongly believes in academic medicine and its each domain - patient care, education, and research. I believe that everyone is given the life with a purpose, and I am privileged to have my current job that has allowed me to have a meaningful impact on the lives of my patients through clinical care and research activities, and the lives of medical students, residents and fellows through teaching.
Revitalization of peritoneal dialysis program and promotion of this under-utilized modality, organization of Annual Cardiorenal Connections CME meeting, establishment of the UTHSA nephrology fellowship as a competitive program in the nation via innovative cardiorenal track and night float system are the highlights of my career. Research activities allow me to quench the thirst for new knowledge and the clinical study “high-dose aldosterone antagonist for decompensated heart failure’ published in Annals of Internal Medicine in 2016 is my pride. The most satisfaction I get is from explaining and teaching renal physiology and disorders to the students or patients and seeing their eyes twinkle with the understanding.
- 2009 - Certificate - Public Health - University of Colorado Health Sciences Center
- 2009 - Postdoctoral Fellowship - Nephrology - University of Colorado Health Sciences Center
- 2009 - Clinical Fellowship - Nephrology - University of Colorado Health Sciences Center
- 2006 - Residency - Internal Medicine - University of Colorado Health Sciences Center
- 2004 - Internship - Internal Medicine - University of Colorado Health Sciences Center
- 2001 - Residency - Internal Medicine - Moulana Azad Medical College
- 1998 - BM BS - Medicine - Swai Man Singh Medical College
Dr Robert Kunau award for excellence in teaching by renal fellows. UTHSCSA, San Antonio, Year 2010-2011, Year 2016-2017.
First prize in Junior Faculty Category – selected for Oral presentation award at Annual Medicine Research Day, May 2016, UTHSCSA, San Antonio.
- 11/2019 - Research Investigator WOC - South Texas Veterans Health Care System, Medicine, San Antonio
- 3/2019 - Director, Nephrology Clinical Research Program - UT Health San Antonio, Medicine, San Antonio
- 2/2018 - Program Director, Nephrology Fellowship - UT Health San Antonio, Medicine, San Antonio
- 9/2016 - Associate Professor / Clinical and Associate Professor of Medicine (Nephrology) - UT Health San Antonio, Medicine, San Antonio
- 11/2015 - Chair, Institutional Review Board-2 - UT Health San Antonio
- 1/2011 - Medical Director - Home Dialysis Program - University Health System, Medicine, San Antonio
Instruction & Training
- 5/2015 - Present, Family and Community Medicine, UTHSCSA
- 11/2013 - Present, Pathophysiology for APN, The University of Texas Health Science Center
- 10/2013 - Present, Medicine Resident Noon Conference, University of Texas Health Science Center at San Antonio
- 5/2013 - Present, Medicine, Behavior Society, The University of Texas Health Science Center
- 8/2012 - Present, Clinical Skills, The University of Texas Health Science Center
- 2/2012 - Present, Medicine Clerkship, The University of Texas Health Science Center
- 9/2011 - Present, Division of Nephrology: Monday Clinical Conference, University of Texas Health Science Center at San Antonio
- 10/2010 - Present, Post Graduate Rotation Supervision, UTHSCSA
Research & Grants
Bayer 17530. Period: 2015- till completion of study “A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven phase 3 study to investigate efficacy and safety of finerenone on the reduction of cardiovascular morbidity and mortality in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease in addition to standard of care. FIGARO DKD Study”
Bayer 16244. Period: 2015- till completion of study “Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease (FIDELIO-DKD)”
University of Pennsylvania Sub award Bansal (PI) 2017- till completion of study Transformative Research in Diabetic Nephropathy (TRIDENT)
Funding Agency AbbVie Title A Randomized, Multicountry, Multicenter,Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and NephropathySONAR: Study Of Diabetic Nephropathywith Atrasentan Status Active Period 8/2013 - Present Role Principal Investigator Grant Detail Site PI. The study objective is to evaluate the effect of atrasentan compared with placebo on time to doubling of serum creatinine or the onset of end stage renal disease (ESRD) in subjects with type 2 diabetes and nephropathy who are treated with the maximum tolerated labeled daily dose (MTLDD) of a Renin-Angiotensin System (RAS) inhibitor. In addition, the study will assess the effects of atrasentan compared with placebo on cardiovascular morbidity and mortality, urine albumin excretion, changes in estimated glomerular filtration rate (eGFR), as well as on the impact on quality of life in subjects with type 2 diabetes and nephropathy.
July 2019 UTSA Pre-freshman Engineering Program (PREP) Career Speaker
May 2020 Career day Speaker at Cambridge Elementary School
November 2019 American Society of Nephrology (ASN) TV news
April 2020 Texas Public Radio Panel discussant for SOURCE: COVID in diabetes and dialysis patients.
June 2020 KENS5 TV coverage for COVID and Kidney Disease
August 2018 Physician Volunteer - Free Health Fair, Indian Association of San Antonio
April 2020 Physician volunteer for Heaven for Hope clinic
Phyo, N, Agarwal, G, Hirachan, P, Gelfond, J, Bansal S. Ergocalciferol supplementation does not reduce the rate of infections and all-cause mortality in hemodialysis patients Dallas, Texas; 2015 Mar. (American Journal of Kidney Diseases). Sultan, G, Manickam, H, Dah, K, Patel, R, Auger, T, Bansal S. PERITONEAL DIALYSIS-RELATED PERITONITIS CAUSED BY STREPTOCCUS BOVIS BIOTYPE-II/1: Dallas, Texas; 2015 Mar. (American Journal of Kidney Diseases). Bansal S, Manickam, Hema, Auger, Tracy, Kessler, Ray, Sultan, Gayeth. PERITONEAL DIALYSIS-RELATED PERITONITIS CAUSED BY STREPTOCCUS BOVIS BIOTYPE-II/1; 2015 Feb. (Journal of Investigative Medicine; vol. 63, no. 2). Bansal S. Fluoroscopically-Guided Percutaneous Peritoneal Dialysis Catheters Placed by Interventional Nephrology for Urgent Start Peritoneal Dialysis Orlando, FL; 2015 Feb. (American Society of Diagnostic and Interventional Nephrology). Agarwal, G, Gelfond, J, Hirachan, P, Fanti P, Bansal S. Effect of Ergocalciferol Treatment on Erythropoietin utilization in Hemodialysis Patients Philadelphia, PA; 2014 Nov. (Journal of American Society of Nephrology). Bansal S, Velagapudi, C, Friedrichs, W, Zarate-Abbott, P, Cunningham, S, Hu, S, Fanti P. Elevated NGAL level in CKD is function of both reduced GFR and circulating neutrophil count Philadelphia, PA; 2014 Nov. (Journal of American Society of Nephrology). Bansal S, Velagapudi, C, Bhandari, B, Werner SL, Fanti P. NGAL and Inflammatory Mediators Stimulate FGF23 Production in in vitro Osteocytes Culture Philadelphia, PA; 2014 Nov. (Journal of American Society of Nephrology). Aderinto, O, Mehanni, C, Khan, F, Gelfond JA, Fanti P, Bansal S. Barriers to timely dialysis access creation: south texas university health system experience; 2014 May. (American Journal of Kidney Diseases; vol. 63, no. 5). Bansal S, Ahmad Mohammad. Emergence of Rapidly Growing Atypical Mycobacterial Exit Site Infection in Current Era of Wide-spread Use of Topical Gentamicin For Exit Site Infection Prophalxis; 2014 Feb. (Journal of Investigative Medicine; vol. 62, no. 2). Bansal S, Khalid, Khazim, Bhandari, B, Werner SL, Abboud HE, Fanti P. NGAL is a Possible Stimulus for Increased FGF23 production Atlanta, GA; 2013 Nov. (Journal of American Society of Nephrology). Fanti P, Khalid, Khazim, Hirachan, P, Cunningham SE, Gross, G, Rossi, R, Giustarini, D, Folli F, Bansal S. Inadequate Dietary Intake Correlates with Thiol Markers of Oxidative Stress in Maintenance Hemodialysis Patients (HD) Atlanta, GA; 2013 Nov. (Journal of American Society of Nephrology). Mehanni, C, Khan, F, Hirachan, p, Gelfond, J, Bansal S. Barriers to Timely Dialysis Access Creation: South Texas University Health System Experience; 2013 Nov. (Journal of American Society of Nephrology).
Linas, S. Management of Hypertension in the ICU. In: Jean-Louis Vincent. Textbook of Critical Care. 2015.
Shi Q., Viswanadhapalli S., Friedrichs W. E., Velagapudi C., Szyndralewiez C., Bansal S. , Bhat M.,*Ghosh Choudhury G and Abboud H. E. (*corresponding author). Nox4 is a target for tuberin deficiency syndrome Scientific Reports 2018 Feb;8. Agarwal, G, Gelfond, J, Hirachan, P, Fanti P, Hura CE, Bansal S. Ergocalciferol Treatment Does Not Improve Erythropoietin Utilization and Hospitalization Rate in Hemodialysis Patients: A case-control study BMC Nephrology 2016 Oct;17(1). Bansal S, Khalid, Khazim, Suri R, Martin, DA, Werner SL, Fanti P. Tumor induced osteomalacia: associated with elevated circulating levels of fibroblast growth factor-7 in addition to fibroblast growth factor-23 Clinical Nephrology 2016 Jan;85(1):57-62. Cunningham SED, Verkaik D, Gross G, Khazim K, Hirachan P, Agarwal G, Lorenzo C, Matteucci E, Bansal S, Fanti P. Comparison of nutritional profile and diet record between veteran and non-veteran ESRD patients receiving hemodialysis in VA and community clinics in metropolitan South-Central Texas Nutrition in Clinical Practice 2015 Oct;30(5):698-708. Fanti P, Giustarini D, Rossi R, Cunningham SED, Folli F, Khazim K, Cornell J, Matteucci E and Bansal S. Dietary Intake of Proteins and Calories is Inversely Associated with the Oxidation State of Plasma Thiols in End-Stage Renal Disease Patients J Renal Nutr 2015 Jun;26(6):494-503. Bansal S. Growing peritoneal dialysis program from 2 to 30 patients in 2 years Peritoneal Dialysis International 2014 Sep;34(6):678-680. Bansal S
Eng M. Use of Natriuretic-doses of Spironolactone for Treatment of Loop Diuretic Resistant Acute Decompensated Heart Failure International Journal of Cardiology 2014 Jan;170(3):e68-e69. Khazim K, Giustarini D, Rossi R, Cornell J, Verkaik D, Cunningham SED, Mohammad M, Trochta K, Lorenzo C, Folli F, Bansal S, Fanti P. Glutathione Redox Potential is Low and Glutathionylated and Cysteinylated Hemoglobin Levels are Elevated in Maintenance Hemodialysis Patients Translational Research 2013 Jul;162(1):16-25. Bansal S, Lindenfeld J, Schrier RW. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist? Circ Heart Fail 2009 Jul;2(4):370-376.
Bansal S, Velagapudi, C, Friedrichs, W, Werner SL, Fanti P. Acute and Chronic Inflammation Raise Plasma FGF23 levels in Normal Mice Journal of American Society of Nephrology 2015 Nov;.
- American Board of Internal Medicine/Nephrology